journal article·2018-01Open access

Magnetically Guided Self‐Assembly and Coding of 3D Living Architectures

Alessandro Tocchio, Naside Gozde Durmus, Kaushik Sridhar, Vigneshwaran Mani, Bukre Coskun, Rami El Assal, Utkan Demirci

Advanced Materials· Volume 30· Issue 4

Abstract

Abstract In nature, cells self‐assemble at the microscale into complex functional configurations. This mechanism is increasingly exploited to assemble biofidelic biological systems in vitro. However, precise coding of 3D multicellular living materials is challenging due to their architectural complexity and spatiotemporal heterogeneity. Therefore, there is an unmet need for an effective assembly method with deterministic control on the biomanufacturing of functional living systems, which can be used to model physiological and pathological behavior. Here, a universal system is presented for 3D assembly and coding of cells into complex living architectures. In this system, a gadolinium‐based nonionic paramagnetic agent is used in conjunction with magnetic fields to levitate and assemble cells. Thus, living materials are fabricated with controlled geometry and organization and imaged in situ in real time, preserving viability and functional properties. The developed method provides an innovative direction to monitor and guide the reconfigurability of living materials temporally and spatially in 3D, which can enable the study of transient biological mechanisms. This platform offers broad applications in numerous fields, such as 3D bioprinting and bottom‐up tissue engineering, as well as drug discovery, developmental biology, neuroscience, and cancer research.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Modular Robots and Swarm Intelligence · Advanced Materials and Mechanics · Micro and Nano Robotics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Bio‐Acoustic MEMS in Medicine (BAMM) Laboratory Canary Center at Stanford for Cancer Early Detection Department of Radiology School of Medicine Stanford University Palo Alto CA 94304 USA

Department of Biochemistry School of Medicine Stanford University Stanford CA 94304 USA

Stanford Genome Technology Center Stanford University Stanford CA 94304 USA

Department of Molecular and Cellular Biology University of California Davis CA 95616 USA

Department of Electrical Engineering (By Courtesy) Stanford University Stanford CA 94305 USA

Funding

National Institutes of Health · National Science Foundation

References (42)

Show source-provided references
1. Tasoglu S. · Nat. Commun. · 2014 · 5
2. 10.1039/b814285h10.1039/b814285h ↗
3. 10.1002/adma.20110196210.1002/adma.201101962 ↗
4. 10.1038/nrm185810.1038/nrm1858 ↗
5. 10.1126/science.309.5731.8410.1126/science.309.5731.84 ↗
6. 10.1038/nature1185910.1038/nature11859 ↗
7. 10.1126/science.849352910.1126/science.8493529 ↗
8. 10.1016/j.mattod.2015.05.00210.1016/j.mattod.2015.05.002 ↗
9. 10.1007/978-1-4614-7876-8_2410.1007/978-1-4614-7876-8_24 ↗
10. 10.1016/j.tcb.2011.09.00510.1016/j.tcb.2011.09.005 ↗
11. 10.1002/bit.2236110.1002/bit.22361 ↗
12. 10.1126/science.107082110.1126/science.1070821 ↗
13. 10.1002/adma.20140207910.1002/adma.201402079 ↗
14. 10.1002/adma.20120028510.1002/adma.201200285 ↗
15. 10.1126/science.291.5504.63010.1126/science.291.5504.630 ↗
16. 10.1063/1.145220610.1063/1.1452206 ↗
17. 10.1116/1.57972610.1116/1.579726 ↗
18. 10.1126/science.289.5482.117010.1126/science.289.5482.1170 ↗
19. 10.1126/science.106915310.1126/science.1069153 ↗
20. 10.1002/biot.20070022810.1002/biot.200700228 ↗
21. 10.1002/1521-4095(200101)13:1<34::AID-ADMA34>3.0.CO;2-110.1002/1521-4095(200101)13:1<34::AID-ADMA34>3.0.CO;2-1 ↗
22. 10.1002/adfm.20030000210.1002/adfm.200300002 ↗
23. 10.1016/j.chom.2011.11.00810.1016/j.chom.2011.11.008 ↗
24. 10.1038/ncb331210.1038/ncb3312 ↗
25. Tasoglu S. · Nat. Commun. · 2014 · 5
26. 10.1038/nnano.2010.2310.1038/nnano.2010.23 ↗
27. 10.1021/cr300068p10.1021/cr300068p ↗
28. FDA Drug Safety Communication: FDA identifies no harmful effects to date with brain retention of gadolinium‐based contrast agents for MRIs; review to continue FDA 2017.
29. 10.1073/pnas.150925011210.1073/pnas.1509250112 ↗
30. 10.1016/S0091-679X(08)00008-310.1016/S0091-679X(08)00008-3 ↗
31. 10.1517/14712598.2012.70718110.1517/14712598.2012.707181 ↗
32. 10.1016/j.pharmthera.2016.03.01310.1016/j.pharmthera.2016.03.013 ↗
33. 10.1038/nrm222210.1038/nrm2222 ↗
34. 10.1016/j.ydbio.2004.11.01210.1016/j.ydbio.2004.11.012 ↗
35. 10.1242/dev.122.5.161110.1242/dev.122.5.1611 ↗
36. 10.1088/1758-5082/2/2/02200110.1088/1758-5082/2/2/022001 ↗
37. 10.2144/00011259110.2144/000112591 ↗
38. 10.1016/j.chembiol.2017.06.01210.1016/j.chembiol.2017.06.012 ↗
39. 10.1016/j.addr.2014.02.00810.1016/j.addr.2014.02.008 ↗
40. 10.1016/j.tibtech.2015.02.00310.1016/j.tibtech.2015.02.003 ↗
41. 10.1038/srep3740710.1038/srep37407 ↗
42. Foty R. · J. Visualized Exp. · 2011